Reversibly Modulating the Blood-Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles
Overview
Authors
Affiliations
The blood-brain barrier (BBB) is highly selective and acts as the interface between the central nervous system and circulation. While the BBB is critical for maintaining brain homeostasis, it represents a formidable challenge for drug delivery. Here we synthesized gold nanoparticles (AuNPs) for targeting the tight junction specifically and demonstrated that transcranial picosecond laser stimulation of these AuNPs post intravenous injection increases the BBB permeability. The BBB permeability change can be graded by laser intensity, is entirely reversible, and involves increased paracellular diffusion. BBB modulation does not lead to significant disruption in the spontaneous vasomotion or the structure of the neurovascular unit. This strategy allows the entry of immunoglobulins and viral gene therapy vectors, as well as cargo-laden liposomes. We anticipate this nanotechnology to be useful for tissue regions that are accessible to light or fiberoptic application and to open new avenues for drug screening and therapeutic interventions in the central nervous system.
Advances in primary large B-cell lymphoma of immune-privileged sites.
Wang L, Guo M, Hou S Front Immunol. 2025; 16:1533444.
PMID: 40078990 PMC: 11896999. DOI: 10.3389/fimmu.2025.1533444.
Luo Q, Yang J, Yang M, Wang Y, Liu Y, Liu J Mater Today Bio. 2025; 31:101457.
PMID: 39896289 PMC: 11786670. DOI: 10.1016/j.mtbio.2025.101457.
Liang K, Yang L, Kang J, Liu B, Zhang D, Wang L Asian J Pharm Sci. 2024; 19(6):100963.
PMID: 39640059 PMC: 11616058. DOI: 10.1016/j.ajps.2024.100963.
Engineering extracellular vesicles to transiently permeabilize the blood-brain barrier.
Tomatis F, Rosa S, Simoes S, Barao M, Jesus C, Novo J J Nanobiotechnology. 2024; 22(1):747.
PMID: 39623431 PMC: 11613868. DOI: 10.1186/s12951-024-03019-w.
Emerging trends in virus and virus-like particle gene therapy delivery to the brain.
Mandalawatta H, Rajendra K, Fairfax K, Hewitt A Mol Ther Nucleic Acids. 2024; 35(3):102280.
PMID: 39206077 PMC: 11350507. DOI: 10.1016/j.omtn.2024.102280.